Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC

NCT06034964 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Tislelizumab
Chemotherapy
First-line
Gastric Cancer Stage IV

Interventions

DRUG: Tislelizumab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences